Ceramide synthase 5

Last updated
Ceramide synthase 5
Identifiers
SymbolCerS5
Alt. symbolsLASS5
NCBI gene 91012
HGNC 23749
OMIM 615335
PDB 2CQX
RefSeq NM_147190
UniProt Q8N5B7
Other data
EC number 2.3.1.24
Locus Chr. 12 q13.12
Search for
Structures Swiss-model
Domains InterPro

Ceramide synthase 5 (CerS5) is the enzyme encoded in humans by the CERS5 gene.

Contents

Function

CerS5 robustly synthesizes C16-ceramide, [1] which is often considered to be an important pro-apoptotic ceramide. [2] De novo ceramide synthesis is an essential trigger for Bax activation in hypoxia/reoxygenation. Following hypoxia/reoxygenation, CerS5 expression is elevated. Upon knocking down acid sphingomyelinase and CerS5 in NTERA-2 cells, Bax localization to mitochondria was reduced, indicating the importance of CerS5 activity in the apoptosis pathway. [3]

Tissue distribution

CerS5 (TRH4) mRNA is found in all tissues and is strongly expressed in muscle and brain. [4] CerS5 is the major ceramide synthase detected in lung epithelia. Knock-down research in respiratory epithelium using CerS5 siRNA or fumonisin B1 reduced total CerS activity by 45% or 78%, respectively, [5] indicating that CerS5 indeed contributes significantly to ceramide synthesis in lung. In the brain, CerS5 mRNA is detected in most cells within the gray and white matter tissues. [6]

Clinical significance

CerS5 sensitizes cells to the chemotherapeutic drugs doxorubicin and vincristine, but not to cisplatin or carboplatin. [7]

A splice variant of CerS5 is expressed in lymphoma and other tumor cells and contribute to tumor recognition by the immune system. [8] In response to upregulation of tumor suppressor protein p53, C16-ceramide levels were increased in leukemia and colon cancer cells, as were levels of CerS5 mRNA in the leukemia cells, but not in the colon cancer cells. For this reason, CerS5 looks like a promising target for the regulation of cancer and of cell death pathways. [9]

Related Research Articles

<span class="mw-page-title-main">Sphingolipid</span> Family of chemical compounds

Sphingolipids are a class of lipids containing a backbone of sphingoid bases, a set of aliphatic amino alcohols that includes sphingosine. They were discovered in brain extracts in the 1870s and were named after the mythological sphinx because of their enigmatic nature. These compounds play important roles in signal transduction and cell recognition. Sphingolipidoses, or disorders of sphingolipid metabolism, have particular impact on neural tissue. A sphingolipid with an R group consisting of a hydrogen atom only is a ceramide. Other common R groups include phosphocholine, yielding a sphingomyelin, and various sugar monomers or dimers, yielding cerebrosides and globosides, respectively. Cerebrosides and globosides are collectively known as glycosphingolipids.

<span class="mw-page-title-main">Ceramide</span> Family of waxy lipid molecules

Ceramides are a family of waxy lipid molecules. A ceramide is composed of N-acetylsphingosine and a fatty acid. Ceramides are found in high concentrations within the cell membrane of eukaryotic cells, since they are component lipids that make up sphingomyelin, one of the major lipids in the lipid bilayer. Contrary to previous assumptions that ceramides and other sphingolipids found in cell membrane were purely supporting structural elements, ceramide can participate in a variety of cellular signaling: examples include regulating differentiation, proliferation, and programmed cell death (PCD) of cells.

<span class="mw-page-title-main">Lipid signaling</span> Biological signaling using lipid molecules

Lipid signaling, broadly defined, refers to any biological signaling event involving a lipid messenger that binds a protein target, such as a receptor, kinase or phosphatase, which in turn mediate the effects of these lipids on specific cellular responses. Lipid signaling is thought to be qualitatively different from other classical signaling paradigms because lipids can freely diffuse through membranes. One consequence of this is that lipid messengers cannot be stored in vesicles prior to release and so are often biosynthesized "on demand" at their intended site of action. As such, many lipid signaling molecules cannot circulate freely in solution but, rather, exist bound to special carrier proteins in serum.

In enzymology, sphingosine N-acyltransferases (ceramide synthases (CerS), EC 2.3.1.24) are enzymes that catalyze the chemical reaction of synthesis of ceramide:

In enzymology, a ceramide kinase, also abbreviated as CERK, is an enzyme that catalyzes the chemical reaction:

In enzymology, a sphingomyelin synthase is an enzyme that catalyzes the chemical reaction

<span class="mw-page-title-main">Protein kinase, AMP-activated, alpha 1</span> Protein-coding gene in the species Homo sapiens

5'-AMP-activated protein kinase catalytic subunit alpha-1 is an enzyme that in humans is encoded by the PRKAA1 gene.

<span class="mw-page-title-main">TRA2B</span> Protein-coding gene in the species Homo sapiens

Transformer-2 protein homolog beta, also known as TRA2B previously known as splicing factor, arginine/serine-rich 10 (SFRS10), is a protein that in humans is encoded by the TRA2B gene.

<span class="mw-page-title-main">ST8SIA1</span> Protein-coding gene in the species Homo sapiens

Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase is an enzyme that in humans is encoded by the ST8SIA1 gene.

<span class="mw-page-title-main">HAS1</span> Protein-coding gene in the species Homo sapiens

Hyaluronan synthase 1 is an enzyme that in humans is encoded by the HAS1 gene.

<span class="mw-page-title-main">UGCG</span> Protein-coding gene in the species Homo sapiens

Ceramide glucosyltransferase is an enzyme that in humans is encoded by the UGCG gene.

<span class="mw-page-title-main">HAS3</span> Protein-coding gene in the species Homo sapiens

Hyaluronan synthase 3 is an enzyme that in humans is encoded by the HAS3 gene.

<span class="mw-page-title-main">ASAH2</span> Protein-coding gene in the species Homo sapiens

Neutral ceramidase is an enzyme that in humans is encoded by the ASAH2 gene.

Gopal Chandra Kundu is an renowned Indian cell and cancer biologist and a Senior Scientist (Scientist-G) at National Centre for Cell Science. He is known for his contributions towards the understanding the mechanism of cancer progression in breast, melanoma and other cancers and development of novel therapeutic targets and target-based therapy in cancers.

Very-long-chain 3-oxoacyl-CoA synthase (EC 2.3.1.199, very-long-chain 3-ketoacyl-CoA synthase, very-long-chain beta-ketoacyl-CoA synthase, condensing enzyme, CUT1 (gene), CERS6 (gene), FAE1 (gene), KCS (gene), ELO (gene)) is an enzyme with systematic name malonyl-CoA:very-long-chain acyl-CoA malonyltransferase (decarboxylating and thioester-hydrolysing). This enzyme catalyses the following chemical reaction

In enzymology, a ceramide phosphoethanolamine synthase is an enzyme that catalyzes the chemical reaction

<span class="mw-page-title-main">Ceramide synthase 1</span> Protein-coding gene in the species Homo sapiens

Ceramide synthase 1 also known as LAG1 longevity assurance homolog 1 is an enzyme that in humans is encoded by the CERS1 gene.

<span class="mw-page-title-main">Ceramide synthase 2</span> Protein-coding gene in the species Homo sapiens

Ceramide synthase 2, also known as LAG1 longevity assurance homolog 2 or Tumor metastasis-suppressor gene 1 protein is an enzyme that in humans is encoded by the CERS2 gene.

<span class="mw-page-title-main">Ceramide synthase 3</span> Protein-coding gene in the species Homo sapiens

Ceramide synthase 3 (CersS3), also known as longevity assurance homologue 3, is an enzyme that is encoded in humans by the CERS3 gene.

Ceramide synthase 4 (CerS4) is an enzyme that in humans is encoded by the CERS4 gene and is one of the least studied of the ceramide synthases.

References

  1. Sujoy Lahiri; Anthony H Futerman (2005). "LASS5 is a bona fide dihydroceramide synthase that selectively utilizes palmitoyl-CoA as acyl donor". J Biol Chem. 280 (40): 33735–8. doi: 10.1074/jbc.m506485200 . PMID   16100120.
  2. Levy M, Futerman AH (2010). "Mammalian ceramide synthases". IUBMB Life. 62 (5): 347–56. doi:10.1002/iub.319. PMC   2858252 . PMID   20222015.
  3. Jin J, Hou Q, Mullen TD, Zeidan YH, Bielawski J, Kraveka JM, et al. (2008). "Ceramide generated by sphingomyelin hydrolysis and the salvage pathway is involved in hypoxia/reoxygenation-induced Bax redistribution to mitochondria in NT-2 cells". J Biol Chem. 283 (39): 26509–17. doi: 10.1074/jbc.M801597200 . PMC   2546549 . PMID   18676372.
  4. Riebeling C, Allegood JC, Wang E, Merrill AH, Futerman AH (Oct 2003). "Two mammalian longevity assurance gene (LAG1) family members, trh1 and trh4, regulate dihydroceramide synthesis using different fatty acyl-CoA donors". J Biol Chem. 278 (44): 43452–9. doi: 10.1074/jbc.M307104200 . PMID   12912983.
  5. Xu Z, Zhou J, McCoy DM, Mallampalli RK (2005). "LASS5 is the predominant ceramide synthase isoform involved in de novo sphingolipid synthesis in lung epithelia". J Lipid Res. 46 (6): 1229–38. doi: 10.1194/jlr.M500001-JLR200 . PMID   15772421.
  6. Becker I, Wang-Eckhardt L, Yaghootfam A, Gieselmann V, Eckhardt M (2008). "Differential expression of (dihydro)ceramide synthases in mouse brain: oligodendrocyte-specific expression of CerS2/Lass2". Histochem Cell Biol. 129 (2): 233–41. doi:10.1007/s00418-007-0344-0. PMID   17901973. S2CID   2595275.
  7. Min J, Mesika A, Sivaguru M, Van Veldhoven PP, Alexander H, Futerman AH, et al. (2007). "(Dihydro)ceramide synthase 1 regulated sensitivity to cisplatin is associated with the activation of p38 mitogen-activated protein kinase and is abrogated by sphingosine kinase 1". Mol Cancer Res. 5 (8): 801–12. doi: 10.1158/1541-7786.MCR-07-0100 . PMID   17699106.
  8. van Hall T, Wolpert EZ, van Veelen P, Laban S, van der Veer M, Roseboom M, et al. (2006). "Selective cytotoxic T-lymphocyte targeting of tumor immune escape variants". Nat Med. 12 (4): 417–24. doi:10.1038/nm1381. PMID   16550190. S2CID   33797315.
  9. Panjarian S, Kozhaya L, Arayssi S, Yehia M, Bielawski J, Bielawska A, et al. (2008). "De novo N-palmitoylsphingosine synthesis is the major biochemical mechanism of ceramide accumulation following p53 up-regulation". Prostaglandins Other Lipid Mediat. 86 (1–4): 41–8. doi:10.1016/j.prostaglandins.2008.02.004. PMID   18400537.